166 related articles for article (PubMed ID: 38405908)
1. Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity.
Gerninghaus J; Zhubi R; Krämer A; Karim M; Tran DHN; Joerger AC; Schreiber C; Berger LM; Berger BT; Ehret TAL; Elson L; Lenz C; Saxena K; Müller S; Einav S; Knapp S; Hanke T
bioRxiv; 2024 Feb; ():. PubMed ID: 38405908
[TBL] [Abstract][Full Text] [Related]
2. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
3. Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors.
Heinzlmeir S; Lohse J; Treiber T; Kudlinzki D; Linhard V; Gande SL; Sreeramulu S; Saxena K; Liu X; Wilhelm M; Schwalbe H; Kuster B; Médard G
ChemMedChem; 2017 Jun; 12(12):999-1011. PubMed ID: 28544567
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
[TBL] [Abstract][Full Text] [Related]
5. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
[TBL] [Abstract][Full Text] [Related]
6. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
7. Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency.
Farand J; Mai N; Chandrasekhar J; Newby ZE; Van Veldhuizen J; Loyer-Drew J; Venkataramani C; Guerrero J; Kwok A; Li N; Zherebina Y; Wilbert S; Zablocki J; Phillips G; Watkins WJ; Mourey R; Notte GT
Bioorg Med Chem Lett; 2016 Dec; 26(24):5926-5930. PubMed ID: 27876318
[TBL] [Abstract][Full Text] [Related]
8. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
[TBL] [Abstract][Full Text] [Related]
9. Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.
Hahn AS; Desrosiers RC
J Virol; 2014 Aug; 88(16):8724-34. PubMed ID: 24899181
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.
Tröster A; DiPrima M; Jores N; Kudlinzki D; Sreeramulu S; Gande SL; Linhard V; Ludig D; Schug A; Saxena K; Reinecke M; Heinzlmeir S; Leisegang MS; Wollenhaupt J; Lennartz F; Weiss MS; Kuster B; Tosato G; Schwalbe H
Chemistry; 2023 Apr; 29(23):e202203967. PubMed ID: 36799129
[TBL] [Abstract][Full Text] [Related]
11. Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus.
Chen J; Sathiyamoorthy K; Zhang X; Schaller S; Perez White BE; Jardetzky TS; Longnecker R
Nat Microbiol; 2018 Feb; 3(2):172-180. PubMed ID: 29292384
[TBL] [Abstract][Full Text] [Related]
12. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
[TBL] [Abstract][Full Text] [Related]
13. Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK).
Asquith CRM; Bennett JM; Su L; Laitinen T; Elkins JM; Pickett JE; Wells CI; Li Z; Willson TM; Zuercher WJ
Molecules; 2019 Nov; 24(22):. PubMed ID: 31698822
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of small molecule agonists of EphA2 receptor.
Petty A; Idippily N; Bobba V; Geldenhuys WJ; Zhong B; Su B; Wang B
Eur J Med Chem; 2018 Jan; 143():1261-1276. PubMed ID: 29128116
[TBL] [Abstract][Full Text] [Related]
16. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
Poulsen A; William A; Blanchard S; Nagaraj H; Williams M; Wang H; Lee A; Sun E; Teo EL; Tan E; Goh KC; Dymock B
J Mol Model; 2013 Jan; 19(1):119-30. PubMed ID: 22820730
[TBL] [Abstract][Full Text] [Related]
18. Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
Heinzlmeir S; Kudlinzki D; Sreeramulu S; Klaeger S; Gande SL; Linhard V; Wilhelm M; Qiao H; Helm D; Ruprecht B; Saxena K; Médard G; Schwalbe H; Kuster B
ACS Chem Biol; 2016 Dec; 11(12):3400-3411. PubMed ID: 27768280
[TBL] [Abstract][Full Text] [Related]
19. EPHA2 Promotes the Invasion and Migration of Human Tongue Squamous Cell Carcinoma Cal-27 Cells by Enhancing AKT/mTOR Signaling Pathway.
Wang F; Zhang H; Cheng Z
Biomed Res Int; 2021; 2021():4219690. PubMed ID: 33834064
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
